Related Experiment Video
Updated: Sep 1, 2026

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess
Published on: March 15, 2024
Maintenance treatment of recurrent duodenal ulceration with pirenzepine
Abstract:
Twenty-eight patients with healed duodenal ulcer completed a 12-month double-blind trial to compare the effects of pirenzepine (25 mg twice daily) and placebo on the prevention of duodenal ulcer relapse. Seven of those on pirenzepine had endoscopically proven recurrent ulcer within a mean of 5 months, while 9 of those on placebo had one after a mean of 5.7 months (n.s.). No untoward effects which could be attributed to the drug were observed during the whole period of treatment.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease I: Introduction
